ES8703023A1 - Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros. - Google Patents

Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.

Info

Publication number
ES8703023A1
ES8703023A1 ES85544483A ES544483A ES8703023A1 ES 8703023 A1 ES8703023 A1 ES 8703023A1 ES 85544483 A ES85544483 A ES 85544483A ES 544483 A ES544483 A ES 544483A ES 8703023 A1 ES8703023 A1 ES 8703023A1
Authority
ES
Spain
Prior art keywords
pct
sample
vitro
blood
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES85544483A
Other languages
English (en)
Other versions
ES544483A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mucan Diagnostics Pty Ltd
Original Assignee
Mucan Diagnostics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucan Diagnostics Pty Ltd filed Critical Mucan Diagnostics Pty Ltd
Publication of ES544483A0 publication Critical patent/ES544483A0/es
Publication of ES8703023A1 publication Critical patent/ES8703023A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

METODO DE DIAGNOSIS CLINICA IN VITRO. CONSISTE EN ENSAYAR UNA MUESTRA DE UN FLUIDO FISIOLOGICO, TAL COMO SANGRE, SUERO SANGUINEO O PLASMA SANGUINEO, EXTRAIDA DEL PACIENTE, PONIENDOLA EN CONTACTO CON ANTICUERPOS MONOCLONALES PARA ANTIGENO MUCINOSO DE INTESTINO DELGADO (SIMA) Y ANTIGENO MUCINOSO DE INTESTINO GRUESO (LIMA) O SUS FRAGMENTOS, MARCADOS CON UNA ENZIMA O UN RADIOISOTOPO, Y DETECTAR LA PRESENCIA DE LA FIJACION DE ESTOS ANTICUERPOS MARCADOS O DE SUS FRAGMENTOS, A SUS CORRESPONDIENTES ANTIGENOS. TIENE APLICACIONES PARA DIAGNOSTICAR CANCER DEL TRACTO GASTROINTESTINAL, DEL PECHO, DE LOS PULMONES, DEL ESTOMAGO Y DE LOS OVARIOS.
ES85544483A 1984-06-25 1985-06-24 Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros. Expired ES8703023A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPG567284 1984-06-25

Publications (2)

Publication Number Publication Date
ES544483A0 ES544483A0 (es) 1987-01-16
ES8703023A1 true ES8703023A1 (es) 1987-01-16

Family

ID=3770652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES85544483A Expired ES8703023A1 (es) 1984-06-25 1985-06-24 Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.

Country Status (15)

Country Link
US (2) US4818682A (es)
EP (1) EP0190159B1 (es)
JP (1) JP2520107B2 (es)
KR (1) KR920010296B1 (es)
CN (1) CN1034976C (es)
AT (1) ATE80470T1 (es)
AU (1) AU596075B2 (es)
CA (1) CA1263598A (es)
DK (1) DK170005B1 (es)
ES (1) ES8703023A1 (es)
GR (1) GR851540B (es)
NZ (1) NZ212419A (es)
PH (1) PH23387A (es)
WO (1) WO1986000414A1 (es)
ZA (1) ZA854700B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160723A (en) * 1985-04-19 1992-11-03 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
JPH0673470B2 (ja) * 1986-07-15 1994-09-21 協和醗酵工業株式会社 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２
JP2519038B2 (ja) * 1986-07-29 1996-07-31 郁男 山科 単クロ―ン抗体及びその製造方法
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5292667A (en) * 1988-06-29 1994-03-08 The General Hospital Corporation Detection and treatment of ulcerative colitis
WO1990012892A1 (en) * 1989-04-14 1990-11-01 The Regents Of The University Of California Human intestinal mucin
WO1991004490A1 (en) * 1989-09-15 1991-04-04 Genetic Systems Corporation Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
US5242799A (en) * 1989-11-02 1993-09-07 Biomira, Inc. Lectin-antibody immunoassays for TF epitope-bearing antigens
US5110911A (en) * 1989-11-02 1992-05-05 Biomira, Inc. Human tumor-associated thomsen-friedenreich antigen
WO1991008217A1 (en) * 1989-12-05 1991-06-13 The Regents Of The University Of California Human intestinal mucins
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
US5278290A (en) * 1991-05-31 1994-01-11 Applied Biotechnology, Inc. Binding protein for CEA and uses thereof
US5245017A (en) * 1991-05-31 1993-09-14 Applied Biotechnology, Inc. Method for isolating CEA-binding protein
US5281697A (en) * 1991-05-31 1994-01-25 Applied Biotechnology, Inc. CEA-binding protein and uses thereof
EP0556496A3 (en) * 1992-02-21 1993-12-29 Dev Ct Biotechnology Antibodies against tumor-associated mucin glycoprotein
AU1257895A (en) * 1993-11-17 1995-06-06 Schepens Eye Research Institute, Inc., The Antibody to ocular and vaginal surface epithelium
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
CA2253093A1 (en) 1998-11-06 2000-05-06 Jiri J. Krepinsky Screening test for early detection of colorectal cancer
SE0004532D0 (sv) * 2000-12-07 2000-12-07 Caldwell Karin Dahlgren Use of mucin
AU2003203034A1 (en) * 2002-01-14 2003-07-30 Vertex Pharmaceuticals Incorporated Mucin immobilized chromatography
ITTO20121154A1 (it) * 2012-12-27 2014-06-28 Fond Istituto Italiano Di Tecnologia Sistema di sonde per rivelare una sequenza nucleotidica bersaglio a singolo filamento

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
DE3485733D1 (de) * 1983-01-21 1992-06-25 Frederick James Primus Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies

Also Published As

Publication number Publication date
DK88086A (da) 1986-02-25
EP0190159A4 (en) 1988-08-04
GR851540B (es) 1985-11-25
ZA854700B (en) 1986-02-26
CN1034976C (zh) 1997-05-21
ES544483A0 (es) 1987-01-16
NZ212419A (en) 1988-08-30
JP2520107B2 (ja) 1996-07-31
KR920010296B1 (ko) 1992-11-21
AU4499685A (en) 1986-01-24
KR860700154A (ko) 1986-03-31
CN85105430A (zh) 1987-05-13
DK170005B1 (da) 1995-04-24
US5008184A (en) 1991-04-16
ATE80470T1 (de) 1992-09-15
PH23387A (en) 1989-07-26
CA1263598A (en) 1989-12-05
US4818682A (en) 1989-04-04
AU596075B2 (en) 1990-04-26
DK88086D0 (da) 1986-02-25
EP0190159B1 (en) 1992-09-09
WO1986000414A1 (en) 1986-01-16
EP0190159A1 (en) 1986-08-13
JPS61502701A (ja) 1986-11-20

Similar Documents

Publication Publication Date Title
ES8703023A1 (es) Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.
IL143892A0 (en) Kidney disease detection and treatment
IN169762B (es)
Go et al. Quantification of carcinoembryonic antigen‐like activities in normal human gastrointestinal secretions
NO932320D0 (no) Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne
AU6828387A (en) Assay for human breast cancer
ZA92389B (en) Method for detection of anti-rna-antibodies
EP0386166A4 (en) Protamine-reactive igm antibodies
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
CA2051885A1 (en) Apparatus for measuring liquid
IL78769A (en) Monoclonal antibodies for non-small cell lung carcinomas(nsclc)and diagnostic method and kit for detecting malignant cells associated with nsclc using such antibodies
AU3485393A (en) Immunological method for the detection of malignant tumours, and a kit for carrying out the method
Tsou et al. 5′-nucleotide phosphodiesterase isoenzyme and hepatic cancer in NCI-Mayo Clinic panel sera
GR3034891T3 (en) Method and kit for predicting the therapeutic response of a drug against a malignant tumour
EP0040020A3 (en) Human reverse transcriptase enzyme, method for its purification, and its use in the detection of breast cancer
Kojima et al. Immunoreactive carcinoembryonic antigen in gastric juice in patients with gastric cancer
DE3586628D1 (en) Immunoassay for detecting cells producing intestinal mucin antigen
JPS56135422A (en) Reagent and method for diagnosis of pancreatic cancer
UA20141A (uk) Спосіб діагhостики первиhhого туберкульозу у дорослих
RU94012403A (ru) Способ дифференциальной диагностики гиперпластических процессов и рака молочной железы в гистологических срезах
DE69023500D1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.
Maeda et al. A case of interstitial pneumonia in polymyositis difficult to distinguish from gold pneumonitis
Saxon Allergy—Important Advances in Clinical Medicine: Clinical Significance of Helper/Suppressor T Cells
UA23350A (uk) Спосіб діагhостики хвороб, що передаються статевим шляхом (сифіліс, сhід, гепатит в та іhші) та автоматизоваhий пристрій для його викоhаhhя
JPS52128212A (en) Reagents for detecting alpha-l-antigen and alpha-l-antibody